Skip to main content
. 2022 Dec 2;10(9):940–957. doi: 10.1002/ueg2.12313
Recommendation 5.32
  • Rifaximin should not be used for secondary prophylaxis of recurrent diverticulitis.

  • Evidence level 5, recommendation grade B, strong consensus